Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

ClinicalTrials.gov ID: NCT02986139

Public ClinicalTrials.gov record NCT02986139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 10:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Crossover Study to Assess the Injection Site Pain Associated With a Modified Etanercept Formulation in Adult Subjects With Either Rheumatoid Arthritis or Psoriatic Arthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective was to assess the injection site pain associated with the new formulation of etanercept compared with commercial etanercept in adults with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) as measured by a visual analog scale (VAS).

Study identification

NCT ID
NCT02986139
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
111 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2016 (Actual)
Primary completion
Sep 8, 2017 (Actual)
Completion
Oct 9, 2017 (Actual)
Last update posted
Jul 18, 2019

2016 – 2017

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Research Site Birmingham Alabama 35216 —
Research Site El Cajon California 92020 —
Research Site Lomita California 90717 —
Research Site Sherman Oaks California 91403 —
Research Site Thousand Oaks California 91320 —
Research Site Cutler Bay Florida 33157 —
Research Site DeLand Florida 32720 —
Research Site Doral Florida 33126 —
Research Site Largo Florida 33770 —
Research Site Miami Florida 33165 —
Research Site Winter Haven Florida 33880 —
Research Site Quincy Illinois 62301 —
Research Site Skokie Illinois 60076 —
Research Site Bay City Michigan 48706 —
Research Site Grand Rapids Michigan 49546 —
Research Site Flowood Mississippi 39232 —
Research Site Kansas City Missouri 64114 —
Research Site Freehold New Jersey 07728 —
Research Site Smithtown New York 11787 —
Research Site Middleburg Heights Ohio 44130 —
Research Site Wyomissing Pennsylvania 19610 —
Research Site Orangeburg South Carolina 29118 —
Research Site Dallas Texas 75231 —
Research Site El Paso Texas 79935 —
Research Site Houston Texas 77034 —
Research Site Mesquite Texas 75150 —
Research Site The Woodlands Texas 77382 —
Research Site Bothell Washington 98021 —
Research Site South Charleston West Virginia 25309 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02986139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 18, 2019 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02986139 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →